Wang C - Search Results

1

Bayesian approaches in medical device clinical trials: a discussion with examples in the regulatory setting.

Bonangelino P, Irony T, Liang S, Li X, Mukhi V, Ruan S, Xu Y, Yang X, Wang C. Bonangelino P, et al. Among authors: wang c. J Biopharm Stat. 2011 Sep;21(5):938-53. doi: 10.1080/10543406.2011.589650. J Biopharm Stat. 2011. PMID: 21830924

2

A note on MAR, identifying restrictions, model comparison, and sensitivity analysis in pattern mixture models with and without covariates for incomplete data.

Wang C, Daniels MJ. Wang C, et al. Biometrics. 2011 Sep;67(3):810-8. doi: 10.1111/j.1541-0420.2011.01565.x. Epub 2011 Mar 1. Biometrics. 2011. PMID: 21361893 Free PMC article.

3

A causal model for joint evaluation of placebo and treatment-specific effects in clinical trials.

Zhang Z, Kotz RM, Wang C, Ruan S, Ho M. Zhang Z, et al. Among authors: wang c. Biometrics. 2013 Jun;69(2):318-27. doi: 10.1111/biom.12005. Epub 2013 Feb 22. Biometrics. 2013. PMID: 23432119 Free PMC article.

4

Optimizing the order of hypotheses in serial testing of multiple endpoints in clinical trials.

Zhang Z, Wang C, Troendle JF. Zhang Z, et al. Among authors: wang c. Stat Med. 2015 Apr 30;34(9):1467-82. doi: 10.1002/sim.6425. Epub 2015 Jan 26. Stat Med. 2015. PMID: 25620627

5

A Bayesian design for phase I cancer therapeutic vaccine trials.

Wang C, Rosner GL, Roden RBS. Wang C, et al. Stat Med. 2019 Mar 30;38(7):1170-1189. doi: 10.1002/sim.8021. Epub 2018 Oct 25. Stat Med. 2019. PMID: 30368868 Free PMC article.

6

A Bayesian nonparametric causal inference model for synthesizing randomized clinical trial and real-world evidence.

Wang C, Rosner GL. Wang C, et al. Stat Med. 2019 Jun 30;38(14):2573-2588. doi: 10.1002/sim.8134. Epub 2019 Mar 18. Stat Med. 2019. PMID: 30883861

7

Propensity score-integrated power prior approach for incorporating real-world evidence in single-arm clinical studies.

Wang C, Li H, Chen WC, Lu N, Tiwari R, Xu Y, Yue LQ. Wang C, et al. J Biopharm Stat. 2019;29(5):731-748. doi: 10.1080/10543406.2019.1657133. Epub 2019 Sep 17. J Biopharm Stat. 2019. PMID: 31530111

8

Propensity score-integrated composite likelihood approach for incorporating real-world evidence in single-arm clinical studies.

Wang C, Lu N, Chen WC, Li H, Tiwari R, Xu Y, Yue LQ. Wang C, et al. J Biopharm Stat. 2020 May 3;30(3):495-507. doi: 10.1080/10543406.2019.1684309. Epub 2019 Nov 10. J Biopharm Stat. 2020. PMID: 31707908

9

Propensity score-integrated composite likelihood approach for augmenting the control arm of a randomized controlled trial by incorporating real-world data.

Chen WC, Wang C, Li H, Lu N, Tiwari R, Xu Y, Yue LQ. Chen WC, et al. Among authors: wang c. J Biopharm Stat. 2020 May 3;30(3):508-520. doi: 10.1080/10543406.2020.1730877. J Biopharm Stat. 2020. PMID: 32370640

10

Evaluation of diagnostic tests for low prevalence diseases: a statistical approach for leveraging real-world data to accelerate the study.

Chen WC, Li H, Wang C, Lu N, Song C, Tiwari R, Xu Y, Yue LQ. Chen WC, et al. Among authors: wang c. J Biopharm Stat. 2021 May 4;31(3):375-390. doi: 10.1080/10543406.2021.1877724. Epub 2021 Feb 21. J Biopharm Stat. 2021. PMID: 33615997

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109,319 results

Search Page

Filters